You are here

New tool to assess costs and benefits of US cancer therapy

Monday, August 24, 2015 - 05:50

Los Angeles

AS options for cancer patients become increasingly complicated, and expensive, the most influential source for US oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies.

The National Comprehensive

Market voices on:

Powered by GET.comGetCom